Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 21
--> References Ames, RG., Steenland, K., Jenkins, B., et al. 1995. Chronic neurologic sequelae to cholinesterase inhibition among agricultural pesticide applicators. Arch Environ Health 50(6):440–444. Anger, W.K., Letz, R., Chrislip, D.W., et al. 1994. Neurobehavioral test methods for environmental health studies of adults. Neurotoxicol Teratol 16(5):489–497. Chaudhry, V., Eisenberger, M.A., Sinibaldi, V.J., et al. 1996. A prospective study of suramin-induced peripheral neuropathy. Brain 119:101–114. Chaudhry, V., Rowinsky, E.K., Sartorius, S.E., et al. 1994. Peripheral neuropathy from Taxol and Cisplatin combination chemotherapy: Clinical and electrophysiological studies. Ann Neurol 35(3):303–311. Davis, C.S. and Richardson, R.J. 1980. Organophosphorus compounds. Experimental and Clinical Neurotoxicology edited by Spencer, P.S. and Schaumburg, H.H. Baltimore: Williams & Wilkins. 527–544. DoD. 1996. Comprehensive Clinical Evaluation Program for Persian Gulf Veterans—Report on 18,598 Participants (Draft). April 1996. Washington, D.C. Dyck, P.J., Dyck, P.J.B., Grant, I.A., et al. 1996. Ten steps in characterizing and diagnosing patients with peripheral neuropathy. Neurology 47:10–17. Feldman, R.G., and White, R.F. 1996. Role of the neurologist in hazard identification and risk assessment. Environ Health Perspect 104(2):227–237. Haley, R.W., and Kurt, T.L. 1997. Self-reported exposure to neurotoxic chemical combinations in the Gulf War. A cross-sectional epidemiologic study. JAMA 277(3):231–237. Haley, R.W., Hom, J., Roland, P.S., et al. 1997a. Evaluation of neurologic function in Gulf War Veterans. A blinded case-control study. JAMA 277(3):223–230.
OCR for page 22
--> Haley, R.W., Kurt, T.L., and Hom, J. 1997b. Is there a Gulf War syndrome? Searching for syndromes by factor analysis of symptoms. JAMA 277(3):215–222. IOM (Institute of Medicine). 1994. Committee on the DoD Persian Gulf Syndrome Comprehensive Clinical Evaluation Program: First Report. Washington, D.C.: IOM. IOM. 1995. Committee on the DoD Persian Gulf Syndrome Comprehensive Clinical Evaluation Program: Second Report. Washington, D.C.: IOM. IOM. 1996a. Evaluation of the U.S. Department of Defense Persian Gulf Comprehensive Clinical Evaluation Program. Washington, D.C.: National Academy Press. IOM 1996b. Health Consequences of Service During the Persian Gulf War: Recommendations for Research and Information Systems. Washington, D.C.: National Academy Press. Iowa Persian Gulf Study Group. 1997. Self-reported illness and health status among Gulf War veterans: A population-based study. JAMA 277(3):238–245. Lotti, M. Moretto, A., Capodicasa, E., et al. 1993. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Toxicol Appl Pharmacol 122:165–171. Marrs, T.C., Maynard, R.L., and Sidell, F.R. 1996 A History of Human Studies with Nerve Agents by the UK and USA in Chemical Warfare Agents: Toxicology and Treatment. New York: John Wiley & Sons. Morita, H., Yanagisawa, N., Nakajima, T., et. al. 1995. Sarin poisoning in Matsumoto, Japan. Lancet 346:290–293. MRICD (Medical Research Institute of Chemical Defense). 1995. Medical Management of Chemical Casualties, Second Edition. Aberdeen Proving Ground, MD: MRICD. NAS (National Academy of Sciences). 1982. Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents. Volume 1: Anticholinesterases and Anticholinergics. Washington, D.C.: National Academy Press. Presidential Advisory Committee on Gulf War Veterans' Illnesses. 1996. Final Report. Washington, D.C.: U.S. Government Printing Office. White, R.F., Gerr, F., Cohen, R.F., et al. 1994. Criteria for progressive modification of neurobehavioral batteries. Neurotoxicol Teratol 16(5):511–524. White, R.F., and Proctor, S.P. 1992. Research and clinical criteria for development of neurobehavioral test batteries. J Occupat Med 34:140–148. Xintaras, C., and Burg, J.A.R. 1980 Screening and prevention of human neurotoxic outbreaks: Issues and problems. Experimental and Clinical Neurotoxicology edited by Spencer, P.S. and Schaumburg, H.H. Baltimore: Williams & Wilkins. 663–674.
Representative terms from entire chapter: